Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Home

aurobindo-pharma

Tag: aurobindo pharma

Read all Latest developments, information and news on and about Aurobindo-pharma - Page 19

Aurobindo Pharma is a pharmaceutical manufacturing company headquartered in Hyderabad manufacturing generic pharmaceuticals and active pharmaceutical ingredients. - Latest Updates

Aurobindo Pharma receives USFDA nod for endometriosis treatment drug

savita thakur thakur11 Jan 2016 9:55 AM IST

New Delhi: Drug firm Aurobindo Pharma has received approval from the US health regulator to manufacture and market generic Norethindrone Acetate...

Aurobindo Pharma gets USFDA nod for acid reflux treatment drug

savita thakur thakur24 Dec 2015 3:25 PM IST

New Delhi: Aurobindo Pharma Ltd said it has received final approval from the US health regulator to manufacture and market Famotidine Tablets used for...

Aurobindo Pharma gets USFDA nod for its conjunctivitis drug

savita thakur thakur22 Dec 2015 5:43 PM IST

New Delhi: Drug firm Aurobindo Pharma has received approval from the US health regulator for generic Olopatadine Hydrochloride ophthalmic solution...

Aurobindo Pharma gets USFDA approval for diarrhoea and allergy drugs

savita thakur thakur18 Dec 2015 1:08 PM IST

Hyderabad: Aurobindo Pharma said it has received final approval from the USFDA to manufacture and market two drugs used for treating diarrhoea and...

US-Based Acorda Therapeutics in Settlement Pact With Aurobindo Pharma

Pooja Bhatia Bhatia14 Dec 2015 10:20 AM IST

Hyderabad: US-based biotechnology company Acorda Therapeutics has said it entered into a settlement agreement with Aurobindo Pharma to...

Aurobindo gets USFDA nod to market heart disease drug

savita thakur thakur10 Dec 2015 12:45 PM IST

NEW DELHI: Aurobindo Pharma has received US health regulator's approval to market Eptifibatide Injection, used in the treatment of acute coronary...

Aurobindo Pharma gets USFDA nod for oral contraceptive tablets

savita thakur thakur10 Dec 2015 11:15 AM IST

NEW DELHI: Drug firm Aurobindo Pharma has received final approval from the US health regulator to manufacture and market its oral contraceptive...

Aurobindo gets USFDA nod for multi disease treatment injection

savita thakur thakur4 Dec 2015 12:02 PM IST

New Delhi: Drug firm Aurobindo Pharma today said it has received final approval of the US health regulator to manufacture and market its Dexamethasone...

Aurobindo gets USFDA nod to market generic Osteoporosis drug

savita thakur thakur2 Dec 2015 1:30 PM IST

New Delhi: Aurobindo Pharma today said it has received final approval from USFDA to manufacture and market generic version of Risedronate Sodium...

Aurobindo Pharma gets USFDA nod for generic of Pfizer's Revatio

Meghna A Singhania22 Nov 2015 3:22 PM IST

New Delhi: Aurobindo Pharma today received final approval from the USFDA to manufacture and market generic version of Pfizer's Revatio (sildenafil...

Aurobindo Pharma's Telangana unit gets approval of the Green Panel

Pooja Bhatia Bhatia14 Oct 2015 10:31 AM IST

To be set up at an investment of about Rs 300 crores, Aurobindo Pharma's manufacturing unit in Telangana has been able to close ranks with the...

Aurobindo Pharma receives FDA approval on drugs to treat psychotic conditions

Pooja Bhatia Bhatia11 Oct 2015 11:39 AM IST

Aurobindo Pharma has received the go-head from USFDA for its drug to treat psychotic conditions. Under the new scheme of things, the company will now...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok